FindTrial
Sign In

How body inflammation and eye scan changes help predict treatment results in patients with diabetic eye swelling.

Comparison of Systemic Inflammation and OCT-Based Biomarkers in Patients with Diabetic Macular Edema and Their Role in Predicting Treatment Outcomes After Ranibizumab Injection - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098727
Enrollment
322
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Anita Kukreja
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: confirmed diagnosis of DME with intraretinal fluid or subretinal fluid on OCT

Exclusion criteria

Exclusion criteria: previous intraocular surgery within 6 months

Design outcomes

Primary

MeasureTime frame
Change in OCT-based biomarkers, central subfield thickness, and presence of pre- and post-ranibizumab injection correlation between systemic inflammatory markers NLR, PLR, and treatment response at 3 and 6 monthsTimepoint: 2 years—

Secondary

MeasureTime frame
Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Soumya H V

JSS Medical College Hospital

soumyahv@jssuni.edu.in9448116151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026